Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Reexamination Certificate
2006-10-17
2006-10-17
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
C424S001110, C424S001650, C424S009100, C424S009400
Reexamination Certificate
active
07122172
ABSTRACT:
Disclosed are Drug Delivery Molecules (DDMs) which both facilitate functional imaging, as by PET or SPECT, and create a biological effect and methods of their use. These DDMs are variously designed to target specific receptors, then become internalized and then function biologically, as for purposes of cell destruction or therapy.
REFERENCES:
patent: 5650134 (1997-07-01), Albert et al.
patent: 5670320 (1997-09-01), Wallace et al.
patent: 5686261 (1997-11-01), Zhang et al.
patent: 5846741 (1998-12-01), Griffiths et al.
patent: 5976496 (1999-11-01), Dean et al.
patent: 6020192 (2000-02-01), Muzyczka
patent: 6074625 (2000-06-01), Hawthorne et al.
patent: 6080728 (2000-06-01), Mixson
patent: 6171859 (2001-01-01), Herrnstadt et al.
patent: 6225284 (2001-05-01), Albert et al.
patent: 6242381 (2001-06-01), Van der Krieken
patent: 6245531 (2001-06-01), Hogness et al.
patent: 6248305 (2001-06-01), Groziak
patent: 6316652 (2001-11-01), Steliou
patent: 6333318 (2001-12-01), Evans et al.
patent: 6432915 (2002-08-01), Bandman et al.
Barth Rolf F.et al., “Enhanced Delivery of Boronophenylalanine for Neutron Capture Therapy of Brain Tumors Using the Bradykinin Analog Cereport (Receptor-Mediated Permeabilizer-7)”, NEUROSURGERY, vol. 44, No. 2, Feb. 1999, pp. 351-360.
Dennie, Joelle et al., “NMR Imaging of Changes In Vascular Morphology Due to Tumor Angiogenesis”, MGH-NMR Center, Dept of Radiology, Jul. 1998, pp. 793-799.
Weissleder, Ralph et al., “In Vivo Magnetic Resonance Imaging of Transgene Expression”, Nature Medicine, vol. 6, No. 3, Mar. 2000, pp. 351-354.
Reddy, Alyssa T. et al., “Pediatric Central Nervous System Tumors”, Current Opinion in Oncology, 1998, pp. 183-193, Lipppincott-Raven.
Hurt, Eduard C. et al., “The Cleavable Prepiece of an Imported Mitochondrial Protein Is Sufficient to Direct Cytosolic Dihydrofolate Reductase Into the Mitochondrial Matrix”, Federation of European Biochemical Societies, vol. 17B, No. 2, pp. 308-310, 1984.
McGarvey, Megan E. et al., “Emerging Treatments for Epidemic (AIDS-related) Kaposi's Sarcoma”, Current Opinion in Oncology, 1998, pp. 413-421.
Smith, Robin A.J. et al., “Selective Targeting of an Antioxidant to Mitochondria”, European Journal of Biochemistry, vol. 263, 1999, pp. 709-716.
Dingwall, Colin et al., “Nuclear Targeting Sequences—a Consensus?”, TIBS 16, Dec. 1991, pp. 478-481, Elsevier Science Publishers (UK).
Grandchamp, Bernard et al., “Molecular Hepatology, Review: Molecular Pathogenesis of Hepatic Acute Porphyrias”, Journal of Gastroenterology and Hepatology, vol. 11, 1996, pp. 1046-1052.
Balistreri, William F., MD, “Inborn Errors of Bile Acid Biosynthesis and Transport, Novel Forms of Metabolic Liver Disease”, Gastroenterology Clinics of North America, vol. 28, No. 1, Mar. 1999, pp. 145-172.
Cox, Diane W., “Disorders of Copper Transport”, British Medical Bulletin, 1999, 55 (No. 3), pp. 544-555.
Tracy Jr., Thomas F. et al., “Molecular and Cellular Control Points in Pediatric Liver Injury and Repair”, Seminars in Pediatric Surgery, vol. 5, No. 3 Aug. 1996, pp. 175-181.
Hartl, Franz-Ulrich et al., “Protein Sorting to Mitochondria: Evolutionary Conservations of Folding and Assembly”, Science, vol. 247, Feb. 1990, pp. 930-938.
Pfanner, Nikolaus et al., “Mitochondrial Preprotein Translocase”, Ann. Rev. Cell Dev. Biol., 1997, 13, pp. 25-51.
Cahill, MR et al., “Haemophilia”, Postgrad Med Journal, 1996, pp. 201-206.
Felipo, Vincente et al., “Mitochondrial Dysfunction In Acute Hyperammonemia”, Neurochemistry International 40, 2002, pp. 487-491.
Treem, William R., M.D. et al., “Disorders of the Mitochondria”, Seminars in Liver Disease, vol. 18, No. 3, 1998, pp. 237-253.
Bakker, Henk D. et al., “Depletion of Mitochondrial Deoxyribonucleic Acid in a Family with Fatal Neonatal Liver Disease”, The Journal of Pediatrics, vol. 128, No. 5, Part 1, pp. 683-687, 1996.
Mazzella, M et al., “Severe Complex I Deficiency in a Case of Neonatal-Onset Lactic Acidosis and Fatal Liver Failure”, Acta Paediatr 86, 1997, pp. 326-329.
Yanagie, H et al., Inhibition of Human Pancreatic Cancer Growth in Nude Mice by Boron Neutron Capture Therapy, British Journal of Cancer, 75(5), 1997, pp. 660-665.
O'Donoghue, Joseph A., “Strategies for Selective Targeting of Auger Electron Emitters to Tumor Cells”, The Journal of Nuclear Medicine, vol. 37, No. 4 (Suppl), Apr. 1996, pp. 3S-6S.
Dwenson, David. H. et al., “Synthesis and Evaluation of a Boronated Nitrolmidazole for Boron Neutron Capture Therapy”, J. Med. Chem, 1996, 39, pp. 1540-1544.
Nguyen, Tien et al., “Intracellular Distribution of Various Boron Compounds for Use In Boron Neutron Capture Therapy”, Biochemical Pharmacology, vol. 45, No. 1, 1993, pp. 147-155.
Fitch Even Tabin & Flannery
Jones Dameron L.
LandOfFree
Methods and compositions for targeted drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for targeted drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for targeted drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614950